Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-market Observational Study to Monitor Safety and Effectiveness in the Treatment of Patients With Ischemic Stroke Using Commercially Approved J&J MedTech Devices Optimized for Neurovascular Thrombectomy

NCT07760649 is registered in ClinicalTrials.gov with Neuravi Limited as lead sponsor.

NCT NCT07760649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07760649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-market Observational Study to Monitor Safety and Effectiveness in the Treatment of Patients With Ischemic Stroke Using Commercially Approved J&J MedTech Devices Optimized for Neurovascular Thrombectomy
Lead sponsor
Neuravi Limited
Phase
Observational
Overall status
Not yet recruiting
Start date
September 23, 2026
Completion date
December 31, 2030
Enrollment
5,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke